Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OssDsign ABOSTO:OSSD -2.72%58 5-Year Yield-on-Cost % is 0.00 as of Jul. 15, 2026. GuruFocus rates OSTO:OSSD with a GF Score™ of 58/100 and a GF Value™ of kr11.15 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 326 Medical Devices & Instruments companies, OssDsign AB ranks worse than 306748.16% on this metric.
OssDsign AB's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for OssDsign AB's 5-Year Yield-on-Cost % or its related term are showing as below:
OSTO:OSSD's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.325 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
OssDsign AB (OSTO:OSSD) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
OssDsign AB 5-Year Yield-on-Cost % Related Terms
OSTO:OSSD vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, OssDsign AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OssDsign AB 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OssDsign AB's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where OssDsign AB's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of OssDsign AB is calculated as
OssDsign AB (OSTO:OSSD) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on OssDsign AB and its competitors. According to the industry distribution chart, OssDsign AB ranks #999999 out of 326 companies in the Medical Devices & Instruments industry.
Is OssDsign AB's 5-Year Yield-on-Cost % too high?
OssDsign AB's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, OssDsign AB ranks #999999 out of 326 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, OssDsign AB has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OssDsign AB's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, OssDsign AB ranks #999999 out of 326 companies for 5-Year Yield-on-Cost %. This places OssDsign AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.33, based on 326 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on OssDsign AB and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OssDsign AB's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OssDsign AB stock overvalued right now?
Based on GuruFocus' analysis, OssDsign AB (OSTO:OSSD) is currently considered Possible Value Trap. The stock's GF Value™ is kr11.15, compared to a current price of kr4.12 — trading 63% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. OssDsign AB's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For OssDsign AB (OSTO:OSSD), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OssDsign AB (OSTO:OSSD) Overvalued in 2026?
Based on GuruFocus' analysis, OssDsign AB stock appears to be undervalued.
The current stock price of kr4.12 is trading 63% below its estimated GF Value™ of kr11.15.
GuruFocus considers OssDsign AB to be Possible Value Trap.
Key valuation signals for OSTO:OSSD:
5-Year Yield-on-Cost %: 0.00
GF Value™: kr11.15 vs. price of kr4.12 (63% below fair value)
No single metric tells the full story. See the OSTO:OSSD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OssDsign AB is a developer and international provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the USA, Germany, Sweden and UK. The company generates the majority of its revenue from the USA region.
58GF Score
Get the complete analysis for OSTO:OSSD
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:OSSD has been successfully added to your 
